Bill > S01029

This bill directs the New York State Commissioner of Health to conduct a comprehensive study on opiate and opioid overdoses by collecting and analyzing 250 anonymous urine samples from patients experiencing moderate to severe overdose symptoms across the state. The samples will be collected with patient consent, following HIPAA regulations, and only from patients in emergency rooms who have been diagnosed with potential opiate/opioid-related medical issues. The samples will be sent to a designated laboratory using advanced testing techniques like liquid chromatography-tandem mass spectrometry (LC-MS-MS) and gas chromatography-mass spectrometry (GC-MS) to identify new, unusual, or unidentified opiate compounds, including combinations with other substances like xylazine. The goal is to understand emerging drug trends and develop more effective medical treatment protocols, especially in cases where traditional overdose treatments like Narcan might be insufficient. Within one year, the Commissioner of Health must submit a report to state leadership and post it online, making the findings available to hospitals and addiction treatment facilities. The study is time-limited and will automatically expire 30 days after the report's delivery.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S1029